The acetylation of transcription factor HBP1 by p300/CBP enhances p16 INK4A expression

Nucleic Acids Research

Volumn 40, Issue 3, 2012, Pages 981-995

  Wang, Weibin ^a   Pan, Kewu ^a   Chen, Yifan ^a   Huang, Chunyin ^b   Zhang, Xiaowei ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; HISTONE ACETYLTRANSFERASE PCAF; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HBP1; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SENESCENCE; TRANSACTIVATION; WESTERN BLOTTING;

ACETYLATION; CELL AGING; CELL LINE; CREB-BINDING PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA; HIGH MOBILITY GROUP PROTEINS; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; LYSINE; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 84863128509     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr818     Document Type: Article

References (36)

1. Berasi, S. P., Xiu, M., Yee, A. S. and Paulson, K. E. (2004) HBP1 repression of the p47phox gene: cell cycle regulation via the NADPH oxidase. Mol. Cell. Biol., 24, 3011-3024.
2. Paulson, K. E., Rieger-Christ, K., McDevitt, M. A., Kuperwasser, C., Kim, J., Unanue, V. E., Zhang, X., Hu, M., Ruthazer, R., Berasi, S. P. et al. (2007) Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer. Cancer Res., 67, 6136-6145.
3. Lavender, P., Vandel, L., Bannister, A. J. and Kouzarides, T. (1997) The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene, 14, 2721-2728.
4. Lemercier, C., Duncliffe, K., Boibessot, I., Zhang, H., Verdel, A., Angelov, D. and Khochbin, S. (2000) Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression. Mol. Cell. Biol., 20, 6627-6637.
5. Shih, H. H., Tevosian, S. G. and Yee, A. S. (1998) Regulation of differentiation by HBP1, a target of the retinoblastoma protein. Mol. Cell. Biol., 18, 4732-4743.
6. Shih, H. H., Xiu, M., Berasi, S. P., Sampson, E. M., Leiter, A., Paulson, K. E. and Yee, A. S. (2001) HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue. Mol. Cell. Biol., 21, 5723-5732.
7. Smith, J. M., Bowles, J., Wilson, M. and Koopman, P. (2004) HMG box transcription factor gene Hbp1 is expressed in germ cells of the developing mouse testis. Dev. Dyn., 230, 366-370.
8. Tevosian, S. G., Shih, H. H., Mendelson, K. G., Sheppard, K. A., Paulson, K. E. and Yee, A. S. (1997) HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev., 11, 383-396.
9. Xiu, M., Kim, J., Sampson, E., Huang, C. Y., Davis, R. J., Paulson, K. E. and Yee, A. S. (2003) The transcriptional repressor HBP1 is a target of the p38 mitogen-activated protein kinase pathway in cell cycle regulation. Mol. Cell. Biol., 23, 8890-8901.
10. Zhang, X., Kim, J., Ruthazer, R., McDevitt, M. A., Wazer, D. E., Paulson, K. E. and Yee, A. S. (2006) The HBP1 transcriptional repressor participates in RAS-induced premature senescence. Mol. Cell. Biol., 26, 8252-8266.
11. Johnstone, R. W. (2002) Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov., 1, 287-299.
12. Marks, P. A., Richon, V. M., Breslow, R. and Rifkind, R. A. (2001) Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol., 13, 477-483.
13. Marks, P. A., Richon, V. M. and Rifkind, R. A. (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl Cancer Inst., 92, 1210-1216.
14. Yu, X., Guo, Z. S., Marcu, M. G., Neckers, L., Nguyen, D. M., Chen, G. A. and Schrump, D. S. (2002) Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. J. Natl Cancer Inst., 94, 504-513.
15. Zhu, W. G. and Otterson, G. A. (2003) The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells. Curr. Med. Chem. Anti-Cancer Agents, 3, 187-199.
16. Chan, H. M., Kristic-Demonacos, M., Smith, L., Demonacos, C. and La Thangue, N. B. (2001) Acetylation control of the retinoblastoma tumour-suppressor protein. Nat. Cell Biol., 3, 667-674.
17. Gu, W. and Roeder, R. G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606.
18. Li, H. K., Wang, W. B., Liu, X. W., Paulson, K. E., Yee, A. S. and Zhang, X. W. (2010) Transcriptional factor HBP1 targets p16INK4A, upregulating its expression and consequently is involved in Ras-induced premature senescence. Oncogene, 29, 5083-5094.
19. Evans, P. M., Zhang, W., Chen, X., Yang, J., Bhakat, K. K. and Liu, C. (2007) Kruppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J. Biol. Chem., 282, 33994-34002.
20. Lee, C. W., Ferreon, J. C., Ferreon, A. C., Arai, M. and Wright, P. E. (2010) Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation. Proc. Natl Acad. Sci. USA, 107, 19290-19295.
21. Wang, F. M., Chen, Y. J. and Ouyang, H. J. (2010) Regulation of unfolded protein response modulator XBP1s by acetylation and deacetylation. Biochem. J., 433, 245-252.
22. Lee, M. and Partridge, N. C. (2010) Parathyroid hormone activation of matrix metalloproteinase-13 transcription requires the histone acetyltransferase activity of p300 and PCAF and p300-dependent acetylation of PCAF. J. Biol. Chem., 285, 38014-38022.
23. Robert, T., Vanoli, F., Chiolo, I., Shubassi, G., Bernstein, K. A., Rothstein, R., Botrugno, O. A., Parazzoli, D., Oldani, A., Minucci, S. et al. (2011) HDACs link the DNA damage response, processing of double-strand breaks and autophagy. Nature, 471, 74-79.
24. Hayflick, L. and Moorhead, P. S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res., 25, 585-621.
25. Kawai, Y., Garduñ o, L., Theodore, M., Yang, J. and Arinze, I. J. (2011) Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related Factor 2) regulates its transcriptional activity and nucleocytoplasmic localization. J. Biol. Chem., 286, 7629-7640.
26. Singh, S. K., Wilczynska, K. M., Grzybowski, A., Yester, J., Osrah, B., Bryan, L., Wright, S., Griswold-Prenner, I. and Kordula, T. (2011) The unique transcriptional activation domain of nuclear factor-I-x3 is critical to specifically induce marker gene expression in astrocytes. J. Biol. Chem., 286, 7315-7326.
27. Jin, Q., Yu, L. R., Wang, L., Zhang, Z., Kasper, L. H., Lee, J. E., Wang, C., Brindle, P. K., Dent, S. Y. and Ge, K. (2011) Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J., 30, 249-262.
28. Duan, J., Zhang, Z. and Tong, T. (2001) Senescence delay of human diploid fibroblast induced by anti-sense p16INK4a expression. J. Biol. Chem., 276, 48325-48331.
29. Glozak, M. A., Sengupta, N., Zhang, X. and Seto, E. (2005) Acetylation and deacetylation of non-histone proteins. Gene., 363, 15-23.
30. Costanzo, A., Merlo, P., Pediconi, N., Fulco, M., Sartorelli, V., Cole, P. A., Fontemaggi, G., Fanciulli, M., Schiltz, L. and Blandino, G. (2002) DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. Mol. Cell., 9, 175-186.
31. Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I. and Pereira-Smith, O. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA, 92, 9363-9367.
32. Shahbazian, M. D. and Grunstein, M. (2007) Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem., 76, 75-100.
33. Mujtaba, S., Zeng, L. and Zhou, M. M. (2007) Structure and acetyl-lysine recognition of the bromodomain. Oncogene, 26, 5521-5527.
34. Yan, J. X., Wait, R., Berkelman, T., Harry, R. A., Westbrook, J. A., Wheeler, C. H. and Dunn, M. J. (2000) A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis, 21, 3666-3672.
35. Yee, A. S., Paulson, E. K., McDevitt, M. A., Rieger-Christ, K., Summerhayes, I., Berasi, S. P., Kim, J., Huang, C. Y. and Zhang, X. (2004) The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppression. Gene, 336, 1-13.
36. Das, C., Lucia, M. S., Hansen, K. C. and Tyler, J. K. (2009) CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature, 459, 113-117.